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Abstract. This article describes the design and evaluation of AutoSyP, a low-cost, low-power syringe pump intended to
deliver intravenous (IV) infusions in low-resource hospitals. A constant-force spring within the device provides mechanical
energy to depress the syringe plunger. As a result, the device can run on rechargeable battery power for 66 hours, a critical
feature for low-resource settings where the power grid may be unreliable. The device is designed to be used with 5- to
60-mL syringes and can deliver fluids at flow rates ranging from 3 to 60 mL/hour. The cost of goods to build one AutoSyP
device is approximately $500. AutoSyP was tested in a laboratory setting and in a pilot clinical study. Laboratory accuracy
was within 4% of the programmed flow rate. The device was used to deliver fluid to 10 healthy adult volunteers and
30 infants requiring IV fluid therapy at Queen Elizabeth Central Hospital in Blantyre, Malawi. The device delivered
fluid with an average mean flow rate error of −2.3% ± 1.9% for flow rates ranging from 3 to 60 mL/hour. AutoSyP has
the potential to improve the accuracy and safety of IV fluid delivery in low-resource settings.
INTRODUCTION
An estimated 15 million premature babies are born every
year, and preterm birth is responsible for more than 1 million
neonatal deaths.1,2 Preterm infants are at increased risk of
dying from various complications, including hypoglycemia,
electrolyte imbalance, and dehydration, for which proper treat-
ment often requires a syringe pump to accurately control intra-
venous (IV) fluid administration.3 Born Too Soon: The Global
Action Report on Preterm Birth identified syringe pumps as
one of the nine most pressing technical innovations needed
to improve care for preterm babies.2 Similarly, the World
Health Organization (WHO) identified syringe pumps that
deliver IV medications as an essential medical device that
should be present at all district hospitals for care of mothers,
newborns, and children.4 Because of their high cost and com-
plexity, commercial-grade syringe pumps are often not readily
available in low-resource settings, where the majority of pre-
term deaths occur.5,6
Without syringe or infusion pumps, hospitals in low-resource
settings deliver fluids with gravity-driven IV drip systems.7
Small neonates require IV fluid to be dispensed at rates
ranging from 60 to 100 mL/kg/day.8 For example, a 1.5 kg
baby receiving 150 mL of fluids per day requires a flow rate
of approximately 6 mL/hour, which is challenging to control
with an IV drip system. These systems have a higher risk of
over- or underhydration due to imprecise flow rate control
and lack of monitoring.9
One alternative method for fluid delivery is Springfusor (Go
Medical Industries, Subiaco, Western Australia), a mechani-
cally driven syringe pump. The Springfusor syringe driver is
available for 10- and 30-mL syringe sizes and can be used
repeatedly on different patients. However, Springfusor has
several limitations that present barriers to adoption in low-
resource settings. Although the syringe driver is reusable
and costs $45 for the 10-mL syringe driver and $52 for the
30-mL syringe driver, each infusion requires a disposable
flow control tube, which costs an additional $4.40–$9.40.10
Precise control of flow rate also requires that the user calcu-
lates a correction factor depending on the fluid delivered and
the environmental conditions, which can be time consuming
in an already time-constrained environment. In addition,
Springfusor can only be used with Braun syringes, creating a
challenge for hospitals where the supply chain for dispos-
ables can be unreliable.11
Thus, there is an important global need for affordable,
accurate, and easy-to-use tools to enable safe delivery of
IV fluids to newborns and infants in low-resource settings.
To meet this need, we designed AutoSyP, an automatic syringe
pump for controlled delivery of IV fluids in low-resource set-
tings. This article describes the design of the AutoSyP device
as well as pilot clinical trials to evaluate its performance in
healthy adult volunteers and in infants requiring IV fluids in a
low-resource hospital.
MATERIALS AND METHODS
Device design. The AutoSyP device is designed to meet
the International Electrotechnical Commission (IEC) standards
for accuracy, and to be low cost, robust, and low power. The
user interface is designed to be simpler than those of commer-
cially available syringe pumps to decrease the risk of user
error. The current prototype can fit syringe sizes of 5, 10, 20,
30, and 60 mL and run from 3 to 60 mL/hour (Figure 1). A
constant-force spring within the device provides energy to
depress the syringe plunger, replacing a significant portion
of the electrical energy that is normally used in syringe
pumps. The spring is set manually by the user between uses
by pulling the depressor to the right edge of the device. The
rate of energy release from the spring, and thus the infusion
flow rate, is controlled by a microcontroller and a stepper
motor within the device.
Figure 2 shows a schematic diagram of AutoSyP. The
device incorporates a rack and pinion system that uses energy
stored in the spring to depress the syringe plunger. The
syringe plunger is attached to the rack, and the spring is used
to move the pinion along the rack at a rate dictated by a
microcontroller. The microcontroller (Figure 2) causes a
motor to spin a cam shaft at the programmed rate. The cam
displaces a flipper, which disengages the pawl from the
ratchet. The disengaged pawl allows the ratchet and pinion
to freely rotate. This allows the spring to move the pinion
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along the rack and depress the syringe plunger. Movement
stops when the second pawl catches the ratchet and locks the
pinion in position. The inclusion of two pawls with the ratchet
ensures that each motor rotation results in one pinion rotation
and thus, one total advancement step. Even though the
advancement of the plunger is triggered by rotation of the
motor, it is driven by the potential energy stored in the spring.
A volume tracker uses a membrane potentiometer to mon-
itor the movement of the depressor. The change in distance
directly correlates to the movement of the syringe plunger
and thus the amount of fluid dispensed. This amount is
displayed on the user interface and is used to monitor the
accuracy of the infusion. If the calculated flow rate deviates
by more than 10% from the programmed flow rate, an accu-
racy alarm is triggered and the infusion stops. A pressure sen-
sor monitors the pressure between the plunger driver and the
syringe plunger, as a surrogate for the pressure in the IV line.
If the pressure exceeds a preprogrammed threshold during
the infusion, the device stops and the alarm system is trig-
gered. This notifies the nurse to check the infusion site for
signs of an occlusion. The occlusion alarm threshold was set
to alarm at a pressure that is 50 mmHg higher than the pres-
sure measured during the initial 10 motor steps of the infusion
for pediatric patients and 100 mmHg higher for adults.
Device use. AutoSyP is operated in a similar manner to
commercial-grade syringe pumps. First, the user pulls back the
device plunger to unwind the spring. The syringe and exten-
sion set are prepared with the prescribed fluid and the
syringe is secured to the device. The user enters the syringe
brand, syringe size, and infusion rate using the five buttons
and screen on the user interface. The user interface displays
the volume dispensed, time remaining, and set infusion rate
during the infusion. During the infusion, the user has the
option to pause the infusion, adjust the initial infusion settings,
or stop the infusion. Visual and audio alarms programmed
on the device indicate pressure occlusions, low accuracy, empty
syringe, or low battery level.
Calibration and laboratory testing protocols. Calibration
was performed using syringe sizes of 10, 20, 30, and 60 mL
and intended flow rates of 5, 10, and 60 mL/hour. The
syringe was prepared with an IV line and catheter for each
calibration test to mimic clinical use. The IV line was primed,
and the syringe was filled to its maximum volume before
being loaded on the AutoSyP device. The rate was set on
the user interface, and the device was programmed to dispense
all fluid in the syringe. During the infusion, a scale connected
to a data recording system tracked the mass of fluid dispensed
into a cup at the distal end of the IV catheter. The mass was
multiplied by the density of the water to convert it to volume.
Using a serial monitor connected to AutoSyP’s microcontrol-
ler, the time and number of half rotations (“steps”) completed
by the device was continuously recorded. Each step from the
serial port was time matched with the fluid dispensed from
the scale data. The amount of volume dispensed at each step
was averaged to determine the average volume dispensed per
step. The calibration protocol was completed three times for
each syringe size and rate. The values from the three calibra-
tion tests were averaged to determine the final calibration
number (mL/step). For all tests, the data from the linear
potentiometer were collected with the serial monitor to deter-
mine the correlation between the linear potentiometer value
and volume dispensed at each step. This correlation was used
FIGURE 1. AutoSyP clinical evaluation system.
FIGURE 2. The spring-gear translation mechanism transfers the spring’s potential energy to the syringe plunger to deliver fluid.
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to calibrate the device’s estimation of current volume dispensed
based on the linear potentiometer value.
Following calibration, benchtop accuracy testing was
performed with 10-, 20-, 30-, and 60-mL syringe sizes. Each
syringe was filled to its maximum volume and separate tests
were conducted at 3, 5, 10, 40, and 60 mL/hour flow rates at
back pressures of 0, 50, and 100 mmHg to mimic clinical
back pressures.12 The entire fluid volume was dispensed and
data from the scale recording system were used to measure
the amount of fluid dispensed over the programmed protocol
time. Back pressure was generated by placing the distal end
of the IV catheter at a specified vertical displacement above
the syringe pump and placing it in water.
Data from each test were collected in accordance to the
IEC standards for electrically driven portable infusion devices
(IEC-60601).13 IEC standards do not have set standards to
calculate mean flow rate over a complete infusion for infusion
periods shorter than 2 hours or flow rates greater than 5mL/hour.
Therefore, the mean flow rate equation for nonelectrically
driven portable infusion devices (International Organization
for Standardization [ISO]-286020) was used to calculate the
average flow rate for each infusion.14 The mean flow rate, Qm,
was determined by measuring the time, T, necessary for the
device to deliver 75% of the nominal volume, Vn, of the solu-
tion. This was calculated using the equation Qm = (0.75 × Vn)/T
(ISO-286020). This method allows for flow rate accuracy com-
parisons to be made for all infusion periods and flow rates.
Trumpet curves were generated following the IEC 60601
standard to assess the variations in flow accuracy throughout
the infusion. Data were analyzed to determine the accuracy of
fluid delivery over specific observation windows across the sec-
ond to sixth hour of a 5 mL/hour infusion. Observation win-
dows were aligned with the time it took AutoSyP to complete
1, 2, 5, 11, 19, and 31 motor steps. The minimum and maxi-
mum flow rate percent errors were calculated for each window.
In accordance with IEC 60601 standards, the maximum
time for activation of the occlusion alarm and the unintended
bolus volume were determined with 5-, 20-, and 60-mL syringes
set to dispense at 5 mL/hour, the required flow rate for IEC
occlusion testing.
Battery life was tested using a new, fully charged cell. The
device was operated continuously at a rate of 5 mL/hour
until the battery voltage dropped below 7 V, the minimum
voltage recommended by the manufacturer for powering
the microcontroller.
Percent errors were calculated for the mean flow rate
error. The calculated mean flow rate was compared with the
programmed flow rate to calculate the mean flow rate error.
Percent errors were compared with the errors reported in
manufacturers specifications for commercial syringe pumps
(±5%) since the IEC standards do not set a percent error
limit or target.
Clinical evaluation protocol. Evaluation of the clinical
accuracy and usability of the device was carried out in a
2-phase clinical trial at Queen Elizabeth Central Hospital
(QECH) in Blantyre, Malawi. The study protocol was approved
by the National Health Science Research Committee of the
Malawi Ministry of Health (protocol no. 1304) and the institu-
tional review board at Rice University (protocol no. 14-150F).
In the first phase, 10 trials were performed. Infusions of
normal saline were administered to healthy adults at flow
rates ranging from 3 to 60 mL/hour with a 10-, 20-, or 60-mL
syringe. This initial study aimed to mimic pediatric infusions
and validate the safety and accuracy of the device in a
healthy, low-risk population.
In the second phase of the study, the accuracy and usability
of AutoSyP was evaluated in its intended clinical setting with
a target patient population. In this phase, 30 babies in the
pediatric department at QECH who had been prescribed IV
fluid infusions were enrolled in the study. Programmed flow
rates and syringe sizes were based on clinician indication
according to the specific needs of the patient. Three staff
nurses were trained on AutoSyP use, clinical preparations,
and study protocol and recruitment procedures. These nurses
managed patient recruitment and consent, programmed infu-
sion settings on the device, and prepared the IV lines and
cannulas during the study. During the infusion, a nurse closely
monitored the device and baby every hour for any infusion-
related complications. In addition, trained technicians moni-
tored the technical performance of the AutoSyP device every
30 minutes and intervened if there were any technical compli-
cations. If the device malfunctioned or an alarm was triggered,
the technician recorded the event and solution on the patient’s
monitoring form to track device performance. If the subject’s
guardian, the nurse, or research technician indicated concern
during the infusion, the treatment was discontinued and the
subject received treatment as necessary using the standard IV
drip system or a commercial syringe pump if it was available.
Data were logged using the serial monitor to track fluid
dispensed, number of motor steps, and any triggered alarms.
Percent errors were calculated for mean flow rate error. The
mean flow rate equation for nonelectrically driven portable
infusion devices (ISO-286020) and the logged data were used
to calculate the average flow rate for each clinical infusion.
The calculated mean flow rate was compared with the
programmed flow rate to calculate the mean flow rate error.
RESULTS
Benchtop testing. Figure 3 shows an example of the
volume dispensed (solid line) over time compared with the
volume tracker (dashed line), which measured the position
of the syringe plunger and the intended fluid delivery rate
(dotted line) for a 30-mL infusion at a rate of 10 mL/hour.
As shown in Figure 3B, a small volume is dispensed with
each motor step. For rates ranging from 3 to 60 mL/hour,
the device had a mean flow rate error of 1.76% ± 1.41% in
laboratory conditions (Table 1). Changing the back pressure
from 0 to 100 mmHg did not affect the mean flow rate error
(P = 0.47).
Figure 4 shows an example trumpet curve. As expected,
the flow rate accuracy improves as fractional errors from
larger observation windows are averaged. The flow rate
error is approximately 25% at the smallest observation
window, but decreases to less than 1% at the largest observa-
tion window.
The average time to alarm and bolus volumes were 1.4,
4.15, and 8.64 minutes and 0.25, 0.30, and 0.66 mL for the 5-,
20-, and 60-mL syringes, respectively. On average, the occlu-
sion was triggered within three motor steps for all syringe
sizes. Battery test results showed that AutoSyP can run con-
tinuously on battery power for up to 66 hours.
Clinical performance. In the first phase of clinical testing,
there was less than 3% error in the mean flow rate for all
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10 healthy volunteer trials (Table 2). A single infusion was
defined as the complete infusion of one syringe. In trials
three and four, patients received multiple infusions using the
same syringe size and flow rate. The average mean flow rate
error over the 10 trials was −0.60% ± 1.65% (95% confi-
dence interval [CI]: −1.61, 0.42). No true occlusions or device
occlusion alarms occurred. There were also no malfunctions
of the device.
In the second phase, 30 pediatric patients were enrolled from
the Chathinka Neonatal Intensive Care Ward, the Pediatric
Nursery High Dependency Unit, and the Pediatric Special
Care Ward. About 59 infusions were completed in this phase.
Patients were given one or multiple infusions of normal saline,
dextrose, Ringer’s lactate (with or without added potassium
chloride) for treatment of dehydration, electrolyte imbalance,
and/or hypoglycemia based on physicians’ orders (Table 3).
The age of subjects ranged from 2 days to 9 months and
weights ranged from 1.2 to 7.8 kg.
Prescribed flow rates varied between 5 and 60 mL/hour,
and prescribed volume delivered per infusion varied between
8 and 60 mL. Syringe sizes for all infusions were 60 mL. The
average for mean flow rate error over the 59 infusions was
−2.27% ± 1.91% (95% CI: −2.76, −1.78) (Figure 5).
During the pediatric patient study, there were 26 infusions
where the occlusion alarm was triggered one or multiple times.
The occlusion alarm alerted the nurse a total of 59 times, and
17 of the triggered occlusion alarms were false alarms. About
42 alarms were true positives, where the IV line occluded and
stopped fluid delivery temporarily until a nurse could correct
the occlusion. Two patients were discharged early and treat-
ment with AutoSyP was discontinued.
DISCUSSION
AutoSyP is a low-power, low-cost device that meets IEC
standards for flow rate accuracy, occlusion alarm testing, and
trumpet curves for electrical syringe pumps and has the poten-
tial to be useful in pediatric wards in low-resource settings.
Our pilot study showed that AutoSyP delivered fluid with a
mean flow rate error of 1.76% in benchtop tests at rates
ranging from 3 to 60 mL/hour. The 10 infusions completed in
healthy adult volunteers were delivered with a −0.6% mean
flow rate error. In 59 infusions completed in pediatric patients,
the mean flow rate error was −2.27%. The mean flow rate
error of AutoSyP is comparable to most electronic commercial-
grade syringe pumps, in which flow rate error ranges from
FIGURE 3. (A) Example benchtop accuracy test data for a 30-mL syringe at 10 mL/hour. (B) Magnified benchtop accuracy data for the same
infusion. The solid line represents volume delivered based on the mass data and the dashed line represents the volume delivered based on AutoSyP’s
internal volume delivery tracking mechanism. The dotted line represents the theoretical volume and the gray area is the ±5% error range.
TABLE 1
Benchtop accuracy test results
Trial no.
Flow rate
(mL/hour)
Syringe
size (mL)
Total volume
delivered (mL)
Back pressure
(mm Hg)
Mean flow
rate error (%)
1 60 60 60 0 2.91
2 40 60 60 0 2.54
3 5 60 60 0 1.52
4 10 30 30 0 2.69
5 5 20 20 0 1.56
6 3 10 10 0 0.75
7 60 60 60 50 2.45
8 60 60 60 100 3.35
9 40 60 60 100 3.50
10 5 60 60 100 1.78
11 10 30 30 100 0.89
12 5 20 20 100 3.69
13 3 10 10 100 1.49
FIGURE 4. Accuracy of fluid delivery as function of observation
windows at 1, 2, 5, 11, 19, and 31 steps were measured to produce
the trumpet curve for a 60-mL syringe at 5 mL/hours. The dashed
line represents the overall percentage error of the infusion. The solid
black line represents the overall percentage error of the second hour
of the infusion.
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±2% to ±5%.15,16 AutoSyP’s battery operating time is
66 hours at 5mL/hour with a rechargeable battery, which is
11 times longer than that of the Alaris (Smith Medical ASD,
Inc., Dublin, OH) and Medfusion (Becton, Dickinson and
Company, Franklin Lakes, NJ) syringe pumps.15,16
The major strengths of the clinical study included testing
in the intended setting and with the intended end users. The
clinical trials took place in the pediatric wards at QECH and
nurses from the wards were hired to set up the device and
IV fluids for each patient. AutoSyP was exposed to the envi-
ronmental challenges in the intended setting (i.e., power out-
ages, line voltage spikes, high temperature, and humidity) and
maintained functionality and accuracy. Feedback collected
from pediatric nurses and physicians assessed the usability of
the device in the wards and to determine design changes
needed. Strengths of the device noted by users included the
simplified and durable design of the device and the recharge-
able battery power source. Users stated that it was easier to
program infusions using AutoSyP than standard commercial
pumps. The staff also noted that the long battery life of the
device decreased the risk of the infusion interruptions due to
power outages.
The limitations of the study included the continuous pres-
ence of technical support in the wards during infusions with
AutoSyP, which would not be representative of permanent,
long-term use of the device. Technical support was included
to mitigate risks during the pilot study and provide immediate
troubleshooting if a malfunction occurred. Future studies
should minimize technical support when the device is regu-
larly being used in the intended setting. Device limitations of
AutoSyP included the large size of the device and low speci-
ficity of the occlusion alarm. AutoSyP is bigger and bulkier
than current commercial syringe pumps. Although this did
not hinder the performance, the device could not easily fit
near the patient without adding benches to accommodate the
device. The size was not practical for the pediatric ward
because most available space was used for patients and their
caregivers. The occlusion alarm had 17 false occlusion alarms
when testing in pediatric patients. A majority of these alarms
were triggered due to patient movements that caused a brief
increase in pressure. In future design iterations, decreasing the
device size and refining the occlusion alarm while maintaining
accuracy will be a key element in the design criteria.
Premature babies in low-resource hospitals require precise
IV administration of fluids to treat high-risk illnesses.2 The
WHO recommends district hospitals have at least one syringe
pump for every two beds located in the pediatric ward to
provide controlled fluid delivery to patients.4 However, the
majority of electric pumps are expensive, complex to use, and
often break down, leaving this population at a high risk for
under- or overdosage when receiving fluids via the alternative
gravity-driven IV drip systems.3,6 Most commercially available
syringe pumps cannot meet the needs of district hospitals in
this setting, limiting the ability to meet the WHO guidelines.
In light of the needs of low-resource hospitals, AutoSyP can
provide a low-cost and durable option to district hospitals while
also maintaining the high accuracy level seen in commercial-
grade syringe pumps. This device will enable nurses and cli-
nicians to provide controlled fluid delivery to severely ill
patients and improve care for babies, pregnant women, and
adults in the low-resource settings.
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